AT122298B - Process for the preparation of cholesterol-free or low-cholesterol solutions of the active substance from glands with internal secretion. - Google Patents

Process for the preparation of cholesterol-free or low-cholesterol solutions of the active substance from glands with internal secretion.

Info

Publication number
AT122298B
AT122298B AT122298DA AT122298B AT 122298 B AT122298 B AT 122298B AT 122298D A AT122298D A AT 122298DA AT 122298 B AT122298 B AT 122298B
Authority
AT
Austria
Prior art keywords
cholesterol
glands
preparation
free
low
Prior art date
Application number
Other languages
German (de)
Original Assignee
Ig Farbenindustrie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ig Farbenindustrie Ag filed Critical Ig Farbenindustrie Ag
Application granted granted Critical
Publication of AT122298B publication Critical patent/AT122298B/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

  

   <Desc/Clms Page number 1> 
 



  Verfahren zur Darstellung von cholesterinfreien bzw.-armen Lösungen der wirksamen
Substanz aus Drüsen mit innerer Sekretion. 



   In dem österreichischen Patente Nr. 113810 ist ein Verfahren zur Darstellung von cholesterinfreien bzw. -armen Lösungen der wirksamen Ovarialsubstanz beschrieben, bei dem man als Reinigungs-bzw. Lösungsmittel wasserlösliche Äther und Ester mehrwertiger Alkohole verwendet. 



   Bei weiterer Bearbeitung dieses Arbeitsgebietes wurde nun die Beobachtung gemacht, dass das beschriebene Verfahren nicht auf die Darstellung von wirksamen Substanzen der Ovarialsubstanzen beschränkt ist, sondern dass auch bei Verwendung anderer Organe oder Drüsen mit innerer Sekretion die wasserlöslichen Äther und Ester mehrwertiger Alkohole als Abscheidungsmittel für Cholesterine oder andere Ballaststoffe sowie als Lösungsmittel der wirksamen Substanz mit Erfolg verwendet werden können. 



   Beispiele :
1.   l/ Hpophysenvorderlappen   werden zerkleinert und mit organischen Lösungsmitteln bei niederer Temperatur extrahiert. Die Konzentration des Gesamtextraktes beträgt ungefähr   60-700/0   an organischem Lösungsmittel. Nach Entfernung des Lösungsmittels wird das Rohkonzentrat in Äther aufgenommen. Die   ätherische   Lösung wird eingedampft und der Rückstand in Diäthylin gelöst. Durch Zusatz von Wasser, dessen Menge sich nach dem Cholesteringehalt des Ausgangsmaterials richtet, wird das Cholesterin in kristalliner Form abgeschieden. Das Filtrat enthält die wirksame Substanz und kann ohne weitere Reinigung verwendet werden. 



   2. 1 leg männliche Keimdrüsen werden nach üblicher Methode mit organischen Lösungsmitteln extrahiert und das Rohkonzentrat in Äther aufgenommen. Die Lösung wird hierauf durch Abdampfen von Äther befreit, der Rückstand in Diäthylin gelöst und aus dieser Lösung die vorhandenen Ballaststoffe durch fraktionierte   Fällung   mit Wasser entfernt. Die nach dem Abfiltrieren gewonnenen Flüssigkeiten enthalten die wirksamen Substanzen in gereinigter Form und können beliebig konzentriert werden. 

**WARNUNG** Ende DESC Feld kannt Anfang CLMS uberlappen**.



   <Desc / Clms Page number 1>
 



  Process for the preparation of cholesterol-free or low-cholesterol solutions of the effective
Substance from glands with internal secretion.



   In the Austrian patent no. 113810 a method for the preparation of cholesterol-free or low-cholesterol solutions of the active ovarian substance is described, in which one as a cleaning or. Solvent water-soluble ethers and esters of polyhydric alcohols are used.



   In further processing of this field of work, the observation was made that the method described is not limited to the preparation of active substances of the ovarian substances, but that also when other organs or glands with internal secretion are used, the water-soluble ethers and esters of polyhydric alcohols as separating agents for cholesterol or other dietary fiber can be used with success as well as a solvent of the active ingredient.



   Examples:
1. L / anterior pituitary lobes are crushed and extracted with organic solvents at low temperature. The concentration of the total extract is approximately 60-700 / 0 in organic solvent. After removing the solvent, the raw concentrate is taken up in ether. The ethereal solution is evaporated and the residue is dissolved in diethyline. By adding water, the amount of which depends on the cholesterol content of the starting material, the cholesterol is deposited in crystalline form. The filtrate contains the active substance and can be used without further purification.



   2. 1 leg male gonads are extracted according to the usual method with organic solvents and the raw concentrate is taken up in ether. The solution is then freed from ether by evaporation, the residue is dissolved in diethyline and the dietary fibers present are removed from this solution by fractional precipitation with water. The liquids obtained after filtering off contain the active substances in purified form and can be concentrated as required.

** WARNING ** End of DESC field may overlap beginning of CLMS **.

 

Claims (1)

PATENT-ANSPRUCH : Verfahren zur Darstellung von cholesterinfreien bzw.-armen Lösungen der wirksamen Substanz aus Drüsen mit innerer Sekretion ausgenommenen Ovarien, dadurch gekennzeichnet, dass man als Reinigungs-bzw. Losungsmittel für die in üblicher Weise aus den Drüsen gewonnenen Rohextrakte wasserlösliche Äther und Ester mehrwertiger Alkohole verwendet. **WARNUNG** Ende CLMS Feld Kannt Anfang DESC uberlappen**. PATENT CLAIM: Process for the preparation of cholesterol-free or low-cholesterol solutions of the active substance from glands with internal secretion gutted ovaries, characterized in that one as cleaning or. Solvent used for the crude extracts obtained in the usual way from the glands, water-soluble ethers and esters of polyhydric alcohols. ** WARNING ** End of CLMS field may overlap beginning of DESC **.
AT122298D 1927-01-11 1927-09-09 Process for the preparation of cholesterol-free or low-cholesterol solutions of the active substance from glands with internal secretion. AT122298B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE122298T 1927-01-11

Publications (1)

Publication Number Publication Date
AT122298B true AT122298B (en) 1931-04-10

Family

ID=29277242

Family Applications (1)

Application Number Title Priority Date Filing Date
AT122298D AT122298B (en) 1927-01-11 1927-09-09 Process for the preparation of cholesterol-free or low-cholesterol solutions of the active substance from glands with internal secretion.

Country Status (1)

Country Link
AT (1) AT122298B (en)

Similar Documents

Publication Publication Date Title
AT122298B (en) Process for the preparation of cholesterol-free or low-cholesterol solutions of the active substance from glands with internal secretion.
DE384134C (en) Process for the production of a chamomile extract
DE552820C (en) Process for the preparation of cholesterol-free or low-cholesterol solutions of the active substance from the anterior pituitary gland and male germ glands
CH349979A (en) Process for the extraction and purification of sapogenins
DE701562C (en) Method for purifying gonad hormones
DE545267C (en) Process for the separate extraction of the hormones contained in the adrenal cortex
DE350377C (en) Process for the extraction and purification of tannins
DE670923C (en) Process for the purification of crude extracts of the corpus luteum hormone
DE430770C (en) Process for the preparation of physiologically active substances
DE733809C (en) Process for the extraction of glycosides from Strophanthus Kombe
AT118754B (en) Process for the preparation of physiologically active substances from male internal secretory organs in a highly purified form.
DE670583C (en) Method for purifying gonad hormones
DE663587C (en) Process for the enrichment and purification of an activator that increases the male sex hormone effect
DE487199C (en) Process for the preparation of purified tuberculin preparations
DE677844C (en) Process for purifying extracts containing the adrenal cortex hormone
AT112461B (en) Process for the extraction and excretion of tartaric acid from its raw materials.
DE651051C (en) Purification process for the production of highly effective estrogenic substances from plant material
DE507794C (en) Process for the preparation of glycerophosphates
DE537162C (en) Process for the usable recovery of lupins
AT202712B (en) Process for the extraction of alkaloids
DE637531C (en) Process for the production of highly effective preparations from corpora lutea
AT144513B (en) Method for excreting the follicular hormone from the urine of pregnant individuals.
DE483394C (en) Process for the production of organophosphorus compounds from plant materials while preserving the vitamins
DE600400C (en) Process for the production of growth hormones or their esters
DE414190C (en) Process for the preparation of citric acid tribenzyl ester